Entry offers an astonishing risk reward ratio up to 20.55
### NOT FINANCIAL ADVICE###
บันทึก
It seems the price has been rejected by the double top. Also the MRNA is dropping, will be watching how it goes, not going to take the trade if correlations are in the way.